Quantification of Myocardial Blood Flow With Ultrasound-Induced Destruction of Microbubbles Administered as a Constant Venous Infusion
- 10 February 1998
- journal article
- other
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 97 (5), 473-483
- https://doi.org/10.1161/01.cir.97.5.473
Abstract
Background—Ultrasound can cause microbubble destruction. If microbubbles are administered as a continuous infusion, then their destruction within the myocardium and measurement of their myocardial reappearance rate at steady state will provide a measure of mean myocardial microbubble velocity. Conversely, measurement of their myocardial concentration at steady state will provide an assessment of microvascular cross-sectional area. Myocardial blood flow (MBF) can then be calculated from the product of the two. Methods and Results—Ex vivo and in vitro experiments were performed in which either flow was held constant and pulsing interval (interval between microbubble destruction and replenishment) was altered, or vice versa. In vivo experiments were performed in 21 dogs. In group 1 dogs (n=7), MBF was mechanically altered in a model in which coronary blood volume was constant. In group 2 dogs (n=5), MBF was altered by direct coronary infusions of vasodilators. In group 3 dogs (n=9), non–flow-limiting coronary stenoses were created, and MBF was measured before and after the venous administration of a coronary vasodilator. In all experiments, microbubbles were delivered as a constant infusion, and myocardial contrast echocardiography was performed using different pulsing intervals. The myocardial video intensity versus pulsing interval plots were fitted to an exponential function: y=A(1−e−βt), where A is the plateau video intensity reflecting the microvascular cross-sectional area, and β reflects the rate of rise of video intensity and, hence, microbubble velocity. Excellent correlations were found between flow and β, as well as flow and the product of A and β. Conclusions—MBF can be quantified with myocardial contrast echocardiography during a venous infusion of microbubbles. This novel approach has potential for measuring tissue perfusion in any organ accessible to ultrasound.Keywords
This publication has 11 references indexed in Scilit:
- Myocardial Perfusion Characteristics and Hemodynamic Profile of MRX-115, a Venous Echocardiographic Contrast Agent, During Acute Myocardial InfarctionJournal of the American Society of Echocardiography, 1998
- Detection of Coronary Artery Disease With Myocardial Contrast EchocardiographyCirculation, 1997
- Interactions Between Microbubbles and Ultrasound: In Vitro and In Vivo ObservationsJournal of the American College of Cardiology, 1997
- Improved myocardial contrast with second harmonic transient ultrasound response imaging in humans using intravenous perfluorocarbon-exposed sonicated dextrose albuminJournal of the American College of Cardiology, 1996
- Quantification of Images Obtained During Myocardial Contrast EchocardiographyEchocardiography, 1994
- Restoration of normal phasic flow velocity after multiple coronary artery stent placementAmerican Heart Journal, 1994
- Transpulmonary Transit of Microbubbles During Contrast Echocardiography: Implications for Estimating Cardiac Output and Pulmonary Blood VolumeJournal of the American Society of Echocardiography, 1993
- Myocardial contrast echocardiography and the transmural distribution of flow: A critical appraisal during myocardial ischemia not associated with infarctionJournal of the American College of Cardiology, 1992
- Simulated Capillary Blood Flow Measurement Using a Nonlinear Ultrasonic Contrast AgentUltrasonic Imaging, 1992
- Myocardial blood flow estimated by synchronous, multislice, high-speed computed tomographyIEEE Transactions on Medical Imaging, 1989